The effects of cholesterol lowering with simvastatin on cause-specific mortality and on cancer incidence in 20,536 high-risk people: a randomised placebo-controlled trial [ISRCTN48489393]

BACKGROUND: There have been concerns that low blood cholesterol concentrations may cause non-vascular mortality and morbidity. Randomisation of large numbers of people to receive a large, and prolonged, reduction in cholesterol concentrations provides an opportunity to address such concerns reliably...

Descripción completa

Detalles Bibliográficos
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1079844/
https://www.ncbi.nlm.nih.gov/pubmed/15771782
http://dx.doi.org/10.1186/1741-7015-3-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1079844/
https://www.ncbi.nlm.nih.gov/pubmed/15771782
http://dx.doi.org/10.1186/1741-7015-3-6

Ejemplares similares